The lesion characteristics of patients with geographic atrophy (GA) were found to affect the lesion growth rate, with ...

Novo Nordisk is paying $240 million up front for global rights to zaltenibart, an Omeros drug that blocks the MASP-3 protein to treat diseases caused by excessive activity of the complement system.

Apellis Pharmaceuticals (NASDAQ: APLS) is preparing to release its quarterly earnings on Thursday, 2025-10-30. Here's a brief overview of what investors should keep in mind before the announcement.

Neil Bressler, M.D., a professor of ophthalmology at Johns Hopkins and editor-in-chief of JAMA Ophthalmology, argued that complement inhibition for geographic atrophy is a game changer. His debating ...

“There are not enough judges to meet the demands of the number of cases in the system,” said Ontario Superior Court Chief ...

The Ferrari 12Cilindri, a masterpiece of automotive engineering and design, has been further refined by NOVITEC, the ...

The residential battery energy storage system is the first non-vehicle product by Ola Electric. This new solution will ...

The Raven system shows how Ukraine’s backers have moved away from purely conventional, big-ticket, high-end systems to more adaptable and agile improvisational ones.

Six thousand hens range under the solar array on 16ha (40 acres) of former arable land let to egg producers Charlie and Laura ...

It’s a mistake to think that criminal justice accountability and addressing root causes of crime in Chicago are mutually exclusive.

Thirty-six years ago, APEC was similarly founded on the principles of trade openness, equality and step-by-step, pragmatic ...